[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359553-105":59,"doc-detail-359553-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nutrient-availability-dictates-cancer-metabolism-based-therapeutic-responses-to-nononcology-drugs","Nutrient Availability Dictates Cancer Metabolism–Based Therapeutic Responses to Nononcology Drugs","","Metabolic dysregulation is a hallmark of cancer, creating therapeutic opportunities by targeting how tumor nutrient availability shapes drug sensitivity. The work clarifies patient-specific nutritional influences on tumor metabolic vulnerability and advances oncometabolic precision medicine by developing the cancer metabolism–based synthetic lethality platform (CM-SLP). CM-SLP performs high-throughput screening to find nutrient-dependent vulnerabilities of cancer cells to nononcology drugs and predicts synthetic lethal interactions, yielding candidates such as propafenone and biguanides.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nutrient-availability-dictates-cancer-metabolism-based-therapeutic-responses-to-nononcology-drugs/359553/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nutrient-availability-dictates-cancer-metabolism-based-therapeutic-responses-to-nononcology-drugs/359553.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main idea behind the CM-SLP platform?","Question",{"text":112,"@type":113},"CM-SLP is a high-throughput screening platform that explores nutrient-availability–dependent metabolic vulnerabilities of cancer cells to nononcology drugs and predicts synthetic lethal interactions with nutrient conditions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which nononcology drug classes were highlighted as promising CM-SLP candidates?",{"text":117,"@type":113},"The abstract highlights propafenone and biguanides as representative nononcology drugs that cooperatively enhanced cytotoxicity through dysregulated metabolic pathways.",{"name":119,"@type":110,"acceptedAnswer":120},"How do nutrient conditions and signaling pathways relate to therapeutic response?",{"text":121,"@type":113},"The response to combined propafenone/hypoglycemia or biguanides/hypoglycemia is mediated by the mTOR and Hippo pathways, respectively, and inhibitors can circumvent dietary interventions to enhance cancer cell death.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359553,1790753078,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Nutrient Availability Dictates Cancer Metabolism–Based Therapeutic Responses to Nononcology Drugs  \nWoo Yang Pyun1, Jae Hyung Park1, Jae Won Roh2, Dongkyu Jeon3, Jongwan Kim4,5, Ji Eun Paik1, Seok Chan Cho1, So Yeon Park1, Hocheol Lim5, Hyungwoo Kim6, Young Jin Jang7, Jaehoon Lee1,8, Jong Hwa Byun1, Dong Woo Son1, Soo-Youl Kim9, Kun-Liang Guan10, Won Dong Lee1,  \nHeon Yung Gee2, Han-Woong Lee1,8, Kyoung Tai No4,5, Yu Suk Choi11, Tadayoshi Hashimoto12, Takayuki Yoshino12, Han-Sol Jeong13, Wan Namkung3, Joo Hyun Nam14,15,16, and Hyun Woo Park1  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Metabolic dysregulation is a major hallmark of cancer, making interventions that modify tumor nutrient availability attractive adjuvants for improving clinical outcomes for patients with cancer. Clarifying how the nutritional status of individual patients affects the metabolic vulnerability of tumors to drugs is needed to inform personalized treatment guidelines. Working toward the goal of oncometabolic precision medicine, we developed the cancer metabolism–based synthetic lethality platform (CM-SLP), a high-throughput screening platform that explores the metabolic vulnerability of cancer cells to nononcology drugs induced by altered nutrient availability and predicts potential synthetic lethal interactions with nutrient conditions. Promising CM-SLP candidates included propafenone and biguanides as representative nononcology drugs that cooperatively enhanced cytotoxicity via dysregulated\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | metabolic pathways. Furthermore, the mTOR and Hippo pathways mediated the response to combined propafenone/ hypoglycemia or biguanides/hypoglycemia treatments, respectively, and mTOR or TEAD inhibitors circumvented the need for dietary interventions to enhance cancer cell death. Together, these results indicate that CM-SLP represents a promising approach for integrating metabolic profiling into precision oncology, offering therapeutic avenues tailored to individual patient needs.\u003Cbr>Significance: A high-throughput screening approach investigating drug vulnerabilities dependent on nutrient status supports repurposing FDA-approved compounds as metabolically informed therapies for next-generation oncometabolic precision medicine. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nCancer progression depends on reprogrammed cellular metabolism to support uncontrolled cell proliferation (1) . Cancer cells exhibit increased nutrient uptake from the tumor microenvironment and altered intracellular pathways to meet the elevated demand for ATP production and biosynthesis of macromolecules required for rapid cell growth (2). The Warburg effect demonstrates the higher demand of cancer cells for glucose than normal cells, which forms the basis for 2[18F]fluoro-2-deoxy-D-glucose PET/CT imaging of cancer. Because cancer cell metabolism is heavily  \n1Department","cbCaidGMZt9Dzywq","https://ap.wps.com/l/cbCaidGMZt9Dzywq","pdf",30660810,21,"English","# Metabolic Rationale and Significance\n## High-throughput CM-SLP Platform\n## Mechanistic Pathway Mediation and Therapeutic Implications\n# Introduction\n## Cancer Metabolism and Nutrient Uptake\n## Imaging and the Warburg Effect\n## Clinical Translation Challenges","[{\"question\":\"What is the main idea behind the CM-SLP platform?\",\"answer\":\"CM-SLP is a high-throughput screening platform that explores nutrient-availability–dependent metabolic vulnerabilities of cancer cells to nononcology drugs and predicts synthetic lethal interactions with nutrient conditions.\"},{\"question\":\"Which nononcology drug classes were highlighted as promising CM-SLP candidates?\",\"answer\":\"The abstract highlights propafenone and biguanides as representative nononcology drugs that cooperatively enhanced cytotoxicity through dysregulated metabolic pathways.\"},{\"question\":\"How do nutrient conditions and signaling pathways relate to therapeutic response?\",\"answer\":\"The response to combined propafenone/hypoglycemia or biguanides/hypoglycemia is mediated by the mTOR and Hippo pathways, respectively, and inhibitors can circumvent dietary interventions to enhance cancer cell death.\"}]","Nutrient Availability Dictates Cancer Metabolism–Based Therapeutic Responses to Nononcology Drugs | PDF",1790137156,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8dcf04339f3e966c3a91f4379e3580ba.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f4f6d17b7b553d2d9ed120c53edfd8a.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d91fc11093ff177f45d4002aa55f8dc3.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c75744594d8d60581ad7381b7839684.webp",980,1311]